None listed
Conditions
Interventions
Medical Device, Procedure/Surgery : Patients are placed in the prone position. The fluoroscopy in anteroposterior view are used to visualize T12 and L1.
The point of entry of the needle below the tran
lidocaine, a 22-G needle was introduced into this point. After confirming the needle position, 5mL of contrast with 5mL of 2%
lidocaine is injected. And then after vital sign monitoring, 10mL of dehydrated alcohol is injected to destroy the celiac plexus.
The endoscopic ultrasound is inserted through the esophagus and approa
Sponsors
Asan Medical Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients with an inoperable pancreatic cancer 2) Patients with upper abdominal or back pain caused by pancreatic cancer 3) 20 years = age < 80 years 4) Patients who have not had a celiac plexus block 5) Patients who have no effect on WHO three step ladder approach 6) Patients with voluntary written consent
Exclusion criteria
Exclusion criteria: 1) Not agree to participate in research 2) Patients with an operable pancreatic cancer 3) Patients with side effects of local anesthetics or steroid 4) when other causes cannot be excluded 5) Patients with coagulopathy or sign of infection 6) Patients with Yellow flag sign 7) Patients with Red flag sign
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Numerical rating scale(NRS) | — |
Secondary
| Measure | Time frame |
|---|---|
| Global perceived effect scale(GPES);NFHSI(NCCN- FACT hepatobiliary symptom index) | — |
Countries
Korea, Republic of
Contacts
Public ContactSeong-Soo Choi
Asan Medical Center
Outcome results
None listed